APA (7th ed.) Citation

He, H., Yan, M., Ye, K., Shi, R., Tong, L., Zhang, S., . . . Zhan, R. (2025). Predicting Prognosis and Immunotherapy Response in Glioblastoma (GBM) With a 5‐Gene CAF‐Risk Signature. Cancer Reports, 8(4), . https://doi.org/10.1002/cnr2.70158

Chicago Style (17th ed.) Citation

He, Haifeng, Min Yan, Ke Ye, Rui Shi, Luqing Tong, Shengxiang Zhang, Yu Zhu, and Renya Zhan. "Predicting Prognosis and Immunotherapy Response in Glioblastoma (GBM) With a 5‐Gene CAF‐Risk Signature." Cancer Reports 8, no. 4 (2025). https://doi.org/10.1002/cnr2.70158.

MLA (9th ed.) Citation

He, Haifeng, et al. "Predicting Prognosis and Immunotherapy Response in Glioblastoma (GBM) With a 5‐Gene CAF‐Risk Signature." Cancer Reports, vol. 8, no. 4, 2025, https://doi.org/10.1002/cnr2.70158.